Axovant Gene Therapies Ltd. (NASDAQ:AXGT) Fell By -2.5%, But Why?

      Comments Off on Axovant Gene Therapies Ltd. (NASDAQ:AXGT) Fell By -2.5%, But Why?

After completing its last trading session, Axovant Gene Therapies Ltd. (NASDAQ:AXGT) dropped by -2.5% – here is what that looked like (as of 2019-12-04):

What is the cause of all this?? To understand this better, it is helpful to analyze some technical indicators. The most important ones are as follows:

A Money Flow Index (MFI) of 34.027, a Relative Strength Index (RSI) of 50.0, a True Strength Index (TSI) of -100.0, a Moving Average Convergence Divergence (MACD) of -0.001, an Average Directional Movement Index (ADX) of unknown, an Average True Range (ATR) of 0.277, an Accumulation/Distribution Index (ADI) of 0.277, an On-Balance Volume (OBV) of 75.219, and a Chaiikin Money Flow (CMF) of -5.29. 2.889

Now let’s plug these indicators in. According to Trading View, putting it all together gets the following:

So there you have it – our analysis of Axovant Gene Therapies Ltd. (NASDAQ:AXGT). Note this is technical analysis only! You should do fundamental research as well, and do not just rely on this – we take no responsibility for any losses incurred if you buy or sell based on the above.